Affordable Access

Publisher Website

An integrated network-based mechanistic model for tumor growth dynamics under drug administration

Authors
Journal
Computers in Biology and Medicine
0010-4825
Publisher
Elsevier
Publication Date
Volume
39
Issue
4
Identifiers
DOI: 10.1016/j.compbiomed.2009.01.014
Keywords
  • Cancer Chemotherapy
  • Mathematical Modeling
  • P53
  • Cell Cycle
  • Multi Scale Modeling
Disciplines
  • Biology
  • Medicine
  • Pharmacology

Abstract

Abstract Cancer chemotherapy complexity ranges from the routes that the drug must follow before reaching the tumor site (pharmacokinetics), to the drug effects on tumor depletion (pharmacodynamics). Previous researchers, in their majority, have focused either on the pharmacokinetics (PK) or on the pharmacodynamics (PD) aspects of chemotherapy. Moreover, models that account for the molecular mechanisms of cancer development have limited scope in addressing the protein signals involved in tumor progression. For instance, the recently developed models for the p53 network, for which a number of mutations have been reported, must be integrated for further understanding of the disease. Here, we propose an integrated model that is composed of a compartmental PK/PD representation for drug therapy that incorporates p53 and cell cycle regulation. In particular, the dynamics of p53 and its network components, such as Mdm2, pRb, cyclin-cdk's, are modeled under drug administration. The results show that the proposed model is a realistic representation of the physiological expectations in a multi-scale, integrative approach.

There are no comments yet on this publication. Be the first to share your thoughts.